TLM Miraj Hospital
(TLM Richardson Leprosy Hospital)

Miraj is located in the Sangli district in the state of Maharashtra. The major industry is sugar manufacturing with seven factories located within the district. Miraj has a high concentration of medical facilities with numerous nursing homes. The private segment of medical facilities is highly sophisticated with super-specialists in every field. However, there is no leprosy hospital or referral centres for quality care for leprosy patients.


TLM Miraj Hospital was established in the year 1896.  

In 1896, Dr William Wanless, a Canadian missionary doctor started an asylum for leprosy patients in Miraj, Maharashtra. Eventually, the Mission to Lepers (now, The Leprosy Mission Trust India) took over the leprosy asylum. The outpatient department was started in 1935. The new hospital complex was inaugurated in 1980 with the introduction of multi-drug therapy (MDT).

Apart from being a full-fledged hospital with leprosy control, training, rehabilitation and research, it also serves as a referral centre for a large catchment area that extends to the whole of western Maharashtra to northern Karnataka. The hospital has been recognised as a centre for reconstructive surgery, rehabilitation and training by the Maharashtra government. It is part of project focussed on health, advocacy, empowerment and development (CHANGED project). The Central Fabrication unit of TLM’s computerised customised protective footwear project is also now in Miraj.

The facilities provided by the hospital include consulting rooms, in-patient rooms, operating theatre, laboratory services, ECG services, X-ray services, counselling, physiotherapy, pharmacy, MCR protective footwear and artificial limbs.

Goal of the hospital

The goal of the hospital is to address the health issues and inclusive development of people affected by leprosy and other marginalised people in the communities in the Sangli and Kolhapur districts of Maharashtra and Belgaum district of Karnataka. The hospital aims to achieve this through:

  • Creating awareness about leprosy in the community for early reporting.
  • Providing hospital-based services and care for physical rehabilitation of people affected by leprosy.
  • Promoting the inclusive development of people affected by leprosy through rights awareness, livelihood opportunities, and advocacy, partnering with other like-minded organisations.
  • Developing partnerships with government, NGOs, churches and community-based organisations for advocacy and livelihood. 



Outpatient Inpatient
The hospital has the following specialities:

  • leprosy treatment and management
  • dermatology
  • general medicine
  • general surgery
  • general physiotherapy
  • reconstructive surgery

In 2015, 1,200 general consultations were provided, with:

  • 57% leprosy
  • 23% dermatology
  • 78% general medicine
The hospital has a 40-bedded in-patient wing and provides best inpatient care with 24-hour nursing care. More than 300 patients were admitted for leprosy care (eye care, ulcer, surgery, lepra reaction and neuritis, etc) in 2015, utilising 7,300 leprosy bed days.






Support services (lab tests; X-ray, ECG, physiotherapy, counselling):

  • 4,200 lab tests, including 680 skin smear examinations for leprosy, 1,600 haematology tests and 1,700 biochemistry tests done in 2015.
  • 41 ECG tests were done.
  • 2,800 leprosy patients counselled.

Prevention of impairment and disability (POID) in leprosy:

The hospital provides patient education, physiotherapy, pre-fabricated splints, MCR protective footwear, etc, to leprosy patients to prevent impairment and disability.

In 2015:

  • 100 leprosy patients diagnosed with reaction/neuritis were treated.
  • 170 ulcer surgeries done.
  • The hospital has an MCR protective footwear manufacturing unit, which supplied 120 pairs to leprosy patients with insensitive
  • The hospital supplied 90 orthoses to leprosy patients.